← All Sponsors
SPONSOR

Meng Chao Hepatobiliary Hospital of Fujian Medical University

Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Hepatocellular Carcinoma
NCT05409482
Recruiting

A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma
China View Trial →